Recent improvements to enhance your investment research experience
360° View free for everyone
Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.
3 new subscription models
Plans for every investor - from stock ideas to in-depth analysis.
Similar Stocks
Four stock alternatives to the stock you're searching.
The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
76 | 80 | 74 | 95 |
Growth
|
70 | 32 | 3 | 11 |
Safety
|
8 | 7 | 6 | 8 |
Sentiment
|
38 | 30 | 8 | 8 |
|
32 | 24 | 6 | 7 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
34 | 33 | 33 | 37 |
Opinions Change
|
50 | 83 | 24 | 50 |
Pro Holdings
|
n/a | 24 | 14 | 32 |
Market Pulse
|
7 | 28 | 20 | 19 |
Sentiment
|
38 | 30 | 8 | 8 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
76 | 80 | 74 | 95 |
Growth
|
70 | 32 | 3 | 11 |
|
8 | 7 | 6 | 8 |
Combined
|
60 | 18 | 6 | 26 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
34 | 26 | 30 | 71 |
Price vs. Earnings (P/E)
|
60 | 72 | 64 | 76 |
Price vs. Book (P/B)
|
73 | 83 | 73 | 87 |
Dividend Yield
|
93 | 93 | 98 | 96 |
Value
|
76 | 80 | 74 | 95 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
14 | 8 | 15 | 11 |
Profit Growth
|
83 | 23 | 6 | 14 |
Capital Growth
|
51 | 68 | 21 | 37 |
Stock Returns
|
84 | 60 | 49 | 65 |
Growth
|
70 | 32 | 3 | 11 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
17 | 14 | 7 | 4 |
Refinancing
|
4 | 19 | 11 | 25 |
Liquidity
|
28 | 16 | 22 | 18 |
|
8 | 7 | 6 | 8 |
Discover high‑ranked alternatives to Takeda Pharmaceutical and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.
30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.